The global CBD-infused skincare market is valued at USD 1,982.1 million in 2026, up from USD 1,752.6 million in 2025, and is projected to reach USD 5,982.1 million by 2036, expanding at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2036, according to Future Market Insights (FMI).

FMI's analysis identifies a shift from niche wellness positioning toward clinically validated, dermatologist-tested skincare formulations. The convergence of clean beauty, plant-based ingredients, and mainstream retail acceptance is creating opportunities for manufacturers. However, regulatory differences across countries and lingering consumer stigma continue to affect market expansion and cross-border commercialization.

Market Size & Growth Forecasts

  • 2025 Market Value: USD 1,752.6 million
  • 2026 Estimated Market Size: USD 1,982.1 million
  • 2036 Projected Market Value: USD 5,982.1 million
  • Forecast CAGR: 11.7% from 2026 to 2036
  • Absolute Dollar Growth: USD 4,229.5 million over the forecast period
  • Market Expansion: More than a threefold increase in market size between 2026 and 2036.

The market covers topical beauty and personal care products formulated with hemp-derived cannabidiol (CBD), including creams, lotions, oils, serums, and balms. These products target anti-inflammatory, acne and blemish care, anti-aging, and soothing applications.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-26600

Key Market Segments

By Function

  • Anti-inflammatory: Expected to account for 53.5% of the market in 2026, supported by demand for products positioned around visible redness reduction, irritation management, and skin calming.
  • Acne/Blemish Care, Anti-aging, and Soothing: These applications broaden the potential uses of CBD-infused skincare across targeted treatments, hydration, and sensitivity-relief routines.

By Product Type

  • Creams and Lotions: Projected to hold 49.5% market share in 2026, reflecting their integration into daily skincare routines and compatibility with established beauty retail channels.
  • Oils, Serums, and Balms: These formats extend product portfolios into concentrated treatments, facial and body care, and targeted applications.

By Consumer Claims

  • Natural/Organic: Expected to command 50.5% share in 2026, reflecting the alignment between CBD-infused skincare and clean beauty preferences.
  • Vegan, Clean-label, and Dermatologist-tested: These claims offer additional positioning opportunities for brands seeking to communicate ingredient transparency and product credibility.

Regional Market Summary

FMI's country-level forecasts identify India and China as high-growth markets, while the United Kingdom, Germany, and the United States contribute to expansion through retail integration and increasing emphasis on product credibility.

  • India: Projected to grow at a 22.0% CAGR from 2026 to 2036, supported by e-commerce adoption and growing interest in natural beauty products.
  • China: Expected to expand at a 20.5% CAGR, reflecting changing beauty consumption patterns and developments in cosmetic ingredient oversight.
  • Japan: Forecast to register a 17.2% CAGR, supported by premium skincare demand and evolving cannabinoid regulations.
  • United Kingdom: Projected to grow at a 14.0% CAGR, with compliance requirements and mainstream retail integration shaping market development.
  • Germany: Expected to record a 10.2% CAGR, with cosmetic safety assessments and ingredient compliance influencing product positioning.
  • United States: Forecast to expand at a 9.2% CAGR, supported by regulatory oversight, ingredient transparency, and dermatologist-aligned product positioning.
  • Brazil: Projected to grow at an 8.5% CAGR, reflecting developments in the regulatory environment for cannabis-derived products.

Major Market Trends and Growth Drivers

Clinical Validation Strengthens Consumer Trust

The market is moving beyond novelty-driven CBD claims toward formulations positioned around specific skincare functions. Dermatologist-tested products, transparent ingredient information, and substantiated product claims are becoming important considerations for manufacturers seeking broader retail acceptance.

Clean Beauty and Premiumization Support Demand

CBD-infused skincare increasingly overlaps with natural and organic, vegan, and clean-label positioning. FMI identifies this convergence as a driver of premiumization, particularly for products addressing skin sensitivity, irritation, and daily hydration.

E-commerce and Pharmacy Distribution Expand Reach

E-commerce allows brands to explain product ingredients and differentiate formulations directly to consumers. Pharmacy distribution also presents an opportunity for products emphasizing dermatological credibility and transparent formulation standards.

Regulatory fragmentation remains a key restraint. Differences in cannabinoid thresholds, labeling requirements, and cosmetic compliance frameworks can complicate product development and cross-border sales. Higher prices relative to conventional botanical skincare may also limit broader adoption.

Competitive Landscape

Competition is increasingly shaped by formulation consistency, reliable hemp sourcing, quality assurance, and regulatory documentation. FMI's analysis indicates that manufacturers with established extraction partnerships, standardized cannabinoid inputs, and strong research and development capabilities may be better positioned to address retailer requirements and consumer concerns.

Key companies profiled include:

CBDfx; Kiehl's (L'Oréal S.A.); Lord Jones; Cannuka; Elixinol; Endoca; Charlotte's Web, Inc.; Medterra; Vertly; The Body Shop International Limited; Josie Maran Cosmetics; Saint Jane Beauty; Prima; Sagely Naturals; CBD For Life; Leef Organics; Myaderm; PureKana; and CBDistillery.

Analyst Perspective

Rahul Pandita, Principal Consultant for Consumer Products at Future Market Insights, states:

"In the updated version of the CBD-Infused Skincare Market Report for 2026 to 2036, beauty brand strategists and retail buyers will find insights into how clinical validation is reshaping consumer trust and how hybrid claims combining vegan, clean-label, and CBD positioning are driving premiumization. Besides this, my findings point at regulatory fragmentation limiting cross-border scaling and the shift toward dermatologist-tested formulations enabling pharmacy channel penetration."

FMI's strategic assessment recommends that market participants prioritize clinically supported product positioning, dermatologist-aligned credibility, transparent sourcing, and e-commerce and pharmacy distribution to reach mainstream consumers.

About Future Market Insights (FMI)

Future Market Insights (FMI) is an ESOMAR-certified market research and consulting organization providing market intelligence, industry analysis, and strategic insights across food and beverage, healthcare, chemicals, technology, packaging, consumer goods, and industrial markets. The company serves clients globally, with its headquarters in Delaware and offices in the United Kingdom, the United Arab Emirates, and India.

Media Contact:

Corporate Communications Team
Future Market Insights (FMI)
Email: sales@futuremarketinsights.com
Phone: +1-347-918-3531

Official Report Page: https://www.futuremarketinsights.com/reports/cbd-infused-skincare-market